Financial Asset Allocations and R&D Activities: Evidence from China's Listed Companies

被引:9
|
作者
Liu, Guanchun [1 ]
Zhang, Jun [2 ,3 ]
Wu, Huihang [1 ]
Peng, Yuchao [4 ]
机构
[1] Shanghai Univ Finance & Econ, Sch Publ Econ & Adm, Shanghai, Peoples R China
[2] Fudan Univ, Sch Econ, Shanghai, Peoples R China
[3] Fudan Univ, Res Inst Chinese Econ, Shanghai, Peoples R China
[4] Cent Univ Finance & Econ, Sch Finance, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
China; financial asset allocations; R&D activities; reservoir; substitution; PANEL-DATA; CASH FLOW; INVESTMENT; DETERMINANTS; CONSTRAINTS; SLOWDOWN; REAL;
D O I
10.1080/1540496X.2018.1451990
中图分类号
F [经济];
学科分类号
02 ;
摘要
Using the semi-annual nonfinancial listed companies from 2007 to 2015, this article investigates the impacts of financial asset allocations on R&D activities in China. Specifically, the ratio of financial asset holding (Fah) and that of financial profit (Fpr) are employed to measure firms' behaviors of financial asset allocations, respectively. The results with dynamic investment-Q framework show that financial asset allocations significantly reduce current firms' innovations, but Fah promotes R&D activities in the next few periods, while Fpr plays an adverse role. Furthermore, the relationships exist in different subsamples, and especially the positive impact of Fah in private firms is stronger than that in state-owned firms. Our findings indicate that, the allocation motivation of Fah as a reservoir and that of Fpr as a substitution are significantly different, which reveal that financial asset allocations perform liking a two-edged sword. Therefore, to avoid deindustrialization and industry hollowing, it is remarkable to supervise the upward trend of financial profit share by firms.
引用
收藏
页码:531 / 544
页数:14
相关论文
共 50 条
  • [1] Is the R&D Expenditure of Listed Companies Green? Evidence from China's A-Share Market
    Li, Boyu
    Li, Lishan
    Pi, Tianlei
    [J]. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (19)
  • [2] Asymmetric Cost Behavior and Investment in R&D: Evidence from China's Manufacturing Listed Companies
    Sun, Renji
    Ho, Kung-Cheng
    Gu, Yan
    Chen, Chang-Chih
    [J]. SUSTAINABILITY, 2019, 11 (06) : 1785
  • [3] Financialization, Government Subsidies, and Manufacturing R&D Investment: Evidence from Listed Companies in China
    Hou, Peng
    Zhou, Mengting
    Xu, Jiaqi
    Liu, Yue
    [J]. SUSTAINABILITY, 2021, 13 (22)
  • [4] Impact of R&D activities on the financial performance: empirical evidence from Indian pharmaceutical companies
    Nandy, Mithun
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICAL AND HEALTHCARE MARKETING, 2022, 16 (02) : 182 - 203
  • [5] Tax Incentives, R&D Manipulation, and Corporate Innovation Performance: Evidence from Listed Companies in China
    Sun, Wenyan
    Yin, Kedong
    Liu, Zhe
    [J]. SUSTAINABILITY, 2021, 13 (21)
  • [6] The chief financial officer (CFO) profile and R&D investment intensity: evidence from listed European companies
    Ginesti, Gianluca
    Spano, Rosanna
    Ferri, Luca
    Caldarelli, Adele
    [J]. MANAGEMENT DECISION, 2021, 59 (13) : 99 - 114
  • [7] The allocation and effectiveness of China's R&D subsidies - Evidence from listed firms
    Boeing, Philipp
    [J]. RESEARCH POLICY, 2016, 45 (09) : 1774 - 1789
  • [8] Ownership structure and R&D spending: evidence from China's listed firms
    Zeng, Tao
    Lin, Horn-Chern
    [J]. CHINESE MANAGEMENT STUDIES, 2011, 5 (01) : 82 - 93
  • [9] R&D spending value effect research of China's listed manufacturing companies
    Zhang, Wanhao
    Chen, Xiding
    [J]. INTERNATIONAL CONFERENCE ON ECONOMICS AND MANAGEMENT INNOVATIONS (ICEMI 2017), VOL 1, ISSUE 1, 2017, : 139 - 141
  • [10] Identification of the enterprise financialization motivation on crowding out R&D innovation: evidence from listed companies in China
    Liu, Yue
    Wen, Yixian
    Xiao, Yulan
    Zhang, Lichang
    Shan, Huang
    [J]. AIMS MATHEMATICS, 2024, 9 (03): : 5951 - 5970